Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:18 AM EDT
336.80quote price arrow up+3.19 (+0.96%)
Volume
2,615
Close
333.61quote price arrow down-1.23 (-0.37%)
Volume
8,295,263
52 week range
65.49 - 497.49
Loading...
  • Open339.11
  • Day High347.87
  • Day Low331.01
  • Prev Close333.61
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap134.662B
  • Shares Out403.65M
  • 10 Day Average Volume12.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change219.34

KEY STATS

  • Open339.11
  • Day High347.87
  • Day Low331.01
  • Prev Close333.61
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20
  • Market Cap134.662B
  • Shares Out403.65M
  • 10 Day Average Volume12.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change219.34

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)41.64
  • Fwd P/E (NTM)7.58
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO5:4405:44
Dr. Patel explains FDA's potential mix-and-match Covid booster strategy

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
262.85+1.76+0.67%
ILMN
Illumina Inc
414.08+3.55+0.86%
REGN
Regeneron Pharmaceuticals Inc
552.11+8.63+1.59%
BIIB
Biogen Inc
268.13-1.60-0.59%
GRFS
Grifols SA
13.60-0.19-1.38%